ERBB2 and breast cancer: According to the expression of estrogen receptors (ER), progesterone receptors (PGR), and human epidermal growth factor receptor 2 (HER2), three subtypes are commonly used for breast cancer clinical classification: the ER/PGR-positive subtype, the HER2-positive subtype, and TNBC, with the most aggressive behavior.